<!DOCTYPE html>
<html>
<head>
    <title>Fast facts - PressReader</title>
    <meta name="description" content="">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20201213/282724819517499" />


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }
    </style>
</head>
<body>
    <div>
        

<article>
    <h1>Fast facts</h1>
    <h2></h2>
    <section>
        <a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a>
        - <a href="/singapore/the-straits-times/20201213/textview" title="The Straits Times - 2020-12-13"><time>2020-12-13</time></a>
        - <span>INVEST</span>
        - <span role="byline"></span>
    </section>

    <p>THE CEO</p>
    <p>Mr John A. Gra­ham has been chief ex­ec­u­tive of Zuel­lig Pharma since July. He is 59 years old.</p>
    <p>He started his ca­reer with Aven­tis, where he spent 18 years in var­i­ous op­er­a­tional and global lead­er­ship po­si­tions, in­clud­ing as head of Global Di­a­betes. Fol­low­ing that, he was man­ag­ing di­rec­tor of Gen­zyme’s op­er­a­tions in Ger­many and Switzer­land be­fore build­ing up a Life Sciences Ad­vi­sory Prac­tice at Ernst & Young.</p>
    <p>From 2008 to 2011, Mr Gra­ham was chief ex­ec­u­tive of­fi­cer of the In­vida Group, a Pan-Asian spe­cial­ity pharma com­pany. In 2011, he ex­e­cuted In­vida’s sale to the Me­nar­ini Group, Italy’s largest pharma com­pany, and was named Me­nar­ini Asia-Pa­cific’s CEO, a po­si­tion he held un­til De­cem­ber 2015. He then worked at New York-based Tor­reya Part­ners, a cor­po­rate fi­nance ad­vi­sory bou­tique firm serv­ing the life sciences in­dus­try and sub­se­quently, be­came chair­man and CEO of In­tegrity Ap­pli­ca­tions, a med­i­cal de­vice com­pany.</p>
    <p>Mr Gra­ham is Bri­tish and was ed­u­cated at board­ing schools Stony­hurst Col­lege and St Ge­orge’s Col­lege. He has a de­gree in bio­chem­istry from Im­pe­rial Col­lege Lon­don. Mr Gra­ham and his wife have two daugh­ters and a son, all em­ployed in the United States.</p>
    <p>THE COM­PANY</p>
    <p>Zuel­lig Pharma is an Asia-fo­cused health­care ser­vices group in­volved in dis­tri­bu­tion, dig­i­tal, pa­tient and com­mer­cial ser­vices. Started in the Philip­pines al­most a cen­tury ago, it is head­quar­tered in Sin­ga­pore.</p>
    <p>The com­pany has a turnover of US$13 bil­lion (S$17.4 bil­lion) cov­er­ing 13 mar­kets.</p>
    <p>It has about 12,000 em­ploy­ees, who serve 350,000 med­i­cal fa­cil­i­ties and cover 500 clients. Zuel­lig Pharma lays claim to be­ing the largest vac­cines and cold chain phar­ma­ceu­ti­cal dis­trib­u­tor in Asia out­side of China and Ja­pan.</p>


</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>

    </div>
    
    <p><a href="http://www.pressreader.com">© PressReader. All rights reserved.</a></p>

        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
            ga('create', 'UA-44408245-1');
            ga('send', 'pageView');
        </script>
</body>
</html>
